Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
256,606,920
-
Total 13F shares
-
230,096,138
-
Share change
-
-3,355,387
-
Total reported value
-
$28,415,941,068
-
Put/Call ratio
-
156%
-
Price per share
-
$123.48
-
Number of holders
-
496
-
Value change
-
-$406,870,829
-
Number of buys
-
235
-
Number of sells
-
213
Institutional Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q2 2015
As of 30 Jun 2015 VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) had 496 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 230,096,138 shares of stock of the company.
Largest 10 holders included Capital World Investors, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, JPMORGAN CHASE & CO, Ameriprise Financial Inc, STATE STREET CORP, Clearbridge Investments, LLC, and BlackRock Institutional Trust Company, N.A..
This table shows 497 institutional shareholders of the security as of 30 Jun 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.